The FDA issued its most serious risk classification—Class I—on March 11, according to the official enforcement notices.

A new lawsuit has been filed against a brand selling popular protein bars over claims the products have more fat and calories in them than the labels have specified.

The company is pursuing a Phase 3 trial in its most exciting pipeline drug, and investors are awaiting potentially exciting ...

Report Highlights the Company's Collaboration with GARDP to Develop NUZOLVENCE (R) (zoliflodacin) for Oral Suspension for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Pediatric ...

Diarrhea Diarrhea was the most common adverse reaction in two randomized, double-blind, placebo-controlled trials of IBS-C. Severe diarrhea was reported in 2.5% of IBSRELA-treated patients. If severe ...

It isn't always all sunshine and wholesale deals at Costco. Here, we've uncovered some of the biggest Kirkland Signature food ...

Lyell Immunopharma, Inc. ( LYEL) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST ...

FDA records list the recall status as ongoing. The recall was initiated on February 10, 2026, and the FDA assigned a Class II ...

Visit CNNhealth.com, your connection for better living "Within a week," she recalled, "I was eating normally again." Scientists have known for decades that probiotics can boost your health. That's why ...

A Walnut Creek pediatrician warns that the CDC’s recent changes to the vaccine schedule will financially debilitate even ...

A norovirus outbreak is now confirmed aboard Westerdam on a 28-night Asia cruise itinerary from Tokyo, with more than 70 ...

At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...